大洋生物：投资者关系活动记录表

Group 1: Company Performance and Financials - The company reported a production capacity of 77,000 tons for potassium carbonate by the end of 2020, maintaining a leading position in the light potassium carbonate sector [2] - The planned production for 2021 includes 88,000 tons of potassium carbonate, 500 tons of ammonium chloride, and 1,600 tons of fluorine fine chemicals [2] - The company experienced a significant increase in production costs due to rising raw material prices, particularly coal, impacting profit margins [4][5] Group 2: Market Position and Competition - The company is one of only two producers of ammonium chloride globally, with a production capacity of 600 tons [2] - The domestic potassium carbonate market has an annual production capacity of 220,000 tons, with a consumption of 171,800 tons in 2019 [6] - The company has established partnerships with over 20 domestic and international listed companies, enhancing its brand and market presence [7] Group 3: Investor Relations and Communication - The company emphasizes the importance of investor relations and actively participates in investor reception activities [1] - There is a commitment to improving communication with investors, including timely updates on company news and performance [7] - The management acknowledges the need for more transparent and meaningful responses to investor inquiries to avoid misunderstandings [7]